Your browser doesn't support javascript.
Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Immunoglobulin Preparations Manufactured From Plasma Collected in the United States and Europe.
Farcet, Maria R; Karbiener, Michael; Knotzer, Simone; Schwaiger, Julia; Kreil, Thomas R.
  • Farcet MR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
  • Karbiener M; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
  • Knotzer S; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
  • Schwaiger J; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
  • Kreil TR; Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
J Infect Dis ; 226(8): 1396-1400, 2022 10 17.
Article in English | MEDLINE | ID: covidwho-2077785
ABSTRACT
After >2 years of the coronavirus disease 2019 (COVID-19) pandemic, immunoglobulins (IGs) contain highly potent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies, based on the large proportion of United States (US) plasma donors who have gone through COVID-19 or vaccination against the virus. Neutralization of Omicron SARS-CoV-2 by antibodies generated after non-Omicron infection or vaccination has been lower though, raising concerns about the potency of IG against this new virus variant. Also, as plasma collected in the US remains the main source of IG, the neutralization of SARS-CoV-2 for plasma collected elsewhere has been less well studied. Here, we confirm Omicron neutralization by US as well as European Union plasma-derived IG lots.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Humans Country/Region as subject: North America / Europa Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Humans Country/Region as subject: North America / Europa Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis